Golinski; Miroslaw Jerzy

Patent Applications and Registrations

Patent applications and USPTO patent grants for Golinski; Miroslaw Jerzy.The latest application filed is for "prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same".

Company Profile

6.14.21

Golinski; Miroslaw Jerzy - Lexington KY
Golinski; Miroslaw Jerzy - La Jolla CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Prodrugs Of Tetrahydrocannabinol, Compositions Comprising Prodrugs Of Tetrahydrocannabinol And Methods Of Using The Same App 20220194916 - Stinchcomb; Audra Lynn ; et al.	2022-06-23
Prodrugs Of Tetrahydrocannabinol, Compositions Comprising Prodrugs Of Tetrahydrocannabinol And Methods Of Using The Same App 20210047284 - Stinchcomb; Audra Lynn ; et al.	2021-02-18
Prodrugs Of Tetrahydrocannabinol, Compositions Comprising Prodrugs Of Tetrahydrocannabinol And Methods Of Using The Same App 20200247774 - Kind Code	2020-08-06
Use of cannabidiol prodrugs in pharmaceutical compositions Grant RE47,885 - Strinchcomb , et al.	2020-03-03
Prodrugs Of Tetrahydrocannabinol, Compositions Comprising Prodrugs Of Tetrahydrocannabinol And Methods Of Using The Same App 20200024248 - Stinchcomb; Audra Lynn ; et al.	2020-01-23
Prodrugs Of Tetrahydrocannabinol, Compositions Comprising Prodrugs Of Tetrahydrocannabinol And Methods Of Using The Same App 20190233387 - Stinchcomb; Audra Lynn ; et al.	2019-08-01
Abuse deterrent opioid/opioid-antagonist transdermal patch Grant 10,238,648 - Stinchcomb , et al.	2019-03-26
Prodrugs Of Tetrahydrocannabinol, Compositions Comprising Prodrugs Of Tetrahydrocannabinol And Methods Of Using The Same App 20190031637 - Stinchcomb; Audra Lynn ; et al.	2019-01-31
Oxymorphone transdermal patch Grant 10,071,090 - Stinchcomb , et al. September 11, 2	2018-09-11
Prodrugs Of Tetrahydrocannabinol, Compositions Comprising Prodrugs Of Tetrahydrocannabinol And Methods Of Using The Same App 20180208572 - Stinchcomb; Audra Lynn ; et al.	2018-07-26
Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same Grant 9,957,246 - Stinchcomb , et al. May 1, 2	2018-05-01
Abuse Deterrent Opiod/opiod-antagonist Transdermal Patch App 20170209429 - STINCHCOMB; Audra Lynn ; et al.	2017-07-27
Oxymorphone Transdermal Patch App 20170202830 - STINCHCOMB; Audra Lynn ; et al.	2017-07-20
Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same Grant 9,695,143 - Stinchcomb , et al. July 4, 2	2017-07-04
Prodrugs Of Tetrahydrocannabinol, Compositions Comprising Prodrugs Of Tetrahydrocannabinol And Methods Of Using The Same App 20170088533 - Stinchcomb; Audra Lynn ; et al.	2017-03-30
Use of cannabidiol prodrugs in topical and transdermal administration with microneedles Grant 9,533,942 - Stinchcomb , et al. January 3, 2	2017-01-03
Prodrugs Of Tetrahydrocannabinol, Compositions Comprising Prodrugs Of Tetrahydrocannabinol And Methods Of Using The Same App 20150218121 - STINCHCOMB; Audra Lynn ; et al.	2015-08-06
Use Of Cannabidiol Prodrugs In Topical And Transdermal Administration With Microneedles App 20150197484 - STINCHCOMB; Audra Lynn ; et al.	2015-07-16
Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same Grant 8,980,942 - Stinchcomb , et al. March 17, 2	2015-03-17
Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists Grant 8,481,560 - Stinchcomb , et al. July 9, 2	2013-07-09
Transdermally Deliverable Opioid Prodrugs, Abuse-resistant Compositions And Methods Of Using Opioid Prodrugs App 20130123292 - STINCHCOMB; Audra Lynn ; et al.	2013-05-16
Prodrugs Of Tetrahydrocannabinol, Compositions Comprising Prodrugs Of Tetrahydrocannabinol And Methods Of Using The Same App 20120289484 - STINCHCOMB; Audra Lynn ; et al.	2012-11-15
Transdermally deliverable opioid prodrugs, abuse-resistant compositions and methods of using opioid prodrugs Grant 8,309,568 - Stinchcomb , et al. November 13, 2	2012-11-13
Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same Grant 8,293,786 - Stinchcomb , et al. October 23, 2	2012-10-23
Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same Grant 8,227,627 - Stinchcomb , et al. July 24, 2	2012-07-24
Abuse Deterrent Transdermal Formulations Of Opiate Agonists And Agonist-antagonists App 20110245783 - Stinchcomb; Audra Lynn ; et al.	2011-10-06
Transdermally Deliverable Opioid Prodrugs, Abuse-resistant Compositions And Methods Of Using Opioid Prodrugs App 20110245288 - Stinchcomb; Audra Lynn ; et al.	2011-10-06
Use Of Cannabidiol Prodrugs In Topical And Transdermal Administration With Microneedles App 20110052694 - Stinchcomb; Audra Lynn ; et al.	2011-03-03
Transdermally Deliverable Opioid Prodrugs, Abuse-Resistant Compositions and Methods of Using Opioid Prodrugs App 20090156814 - Stinchcomb; Audra Lynn ; et al.	2009-06-18
Products of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same App 20090143462 - Stinchcomb; Audra Lynn ; et al.	2009-06-04
Transdermally deliverable opioid prodrugs, abuse-resistant compositions and methods of using opioid prodrugs Grant 7,511,054 - Stinchcomb , et al. March 31, 2	2009-03-31
Prodrugs Of Cannabidiol, Compositions Comprising Prodrugs Of Cannabidiol And Methods Of Using The Same App 20090036523 - Stinchcomb; Audra Lynn ; et al.	2009-02-05
Transdermally Deliverable Opioid Prodrugs, Abuse-resistant Compositions And Methods Of Using Opioid Prodrugs App 20080076789 - Stinchcomb; Audra Lynn ; et al.	2008-03-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.